Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors

BMC Microbiology

Volumn 6, Issue , 2006, Pages

  Popova, Taissia G ^a   Millis, Bryan ^a   Bradburne, Chris ^a   Nazarenko, Svetlana ^a   Bailey, Charles ^a   Chandhoke, Vikas ^a   Popov, Serguei G ^a  

^a GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE SYK; STRESS ACTIVATED PROTEIN KINASE; SYNDECAN 1; UVOMORULIN; VIRULENCE FACTOR; ANTHRAX TOXIN; BACTERIAL ANTIGEN; BACTERIAL TOXIN; CADHERIN; HEMOLYSIN; LACTATE DEHYDROGENASE; PHOSPHATIDYLCHOLINE SPECIFIC PHOSPHOLIPASE C; PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE C; PHOSPHOLIPASE C; SPHINGOMYELIN PHOSPHODIESTERASE;

ACCELERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACILLUS CEREUS; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; HEMOLYSIS; IN VITRO STUDY; LETHAL GENE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; DBA MOUSE; HUMAN; METABOLISM; MICROBIOLOGY; SECRETION (PROCESS);

ANIMALIA; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CADHERINS; CELL LINE; EPITHELIAL CELLS; HEMOLYSIN PROTEINS; HUMANS; L-LACTATE DEHYDROGENASE; MICE; MICE, INBRED DBA; SPHINGOMYELIN PHOSPHODIESTERASE; SYNDECAN-1; TYPE C PHOSPHOLIPASES; VIRULENCE FACTORS;

EID: 33644648573     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-6-8     Document Type: Article

References (52)

1. Park PW, Pier GB, Preston MJ, Goldberger O, Fitzgerald ML, Bernfield M: Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J Biol Chem 2000, 275:3057-3064.
2. Park PW, Pier GB, Hinkes MT, Bernfield M: Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 2001, 411:98-102.
3. Park PW, Foster TJ, Nishi E, Duncan SJ, Klagsbrun M, Chen Y: Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus alpha-toxin and beta-toxin. J Biol Chem 2004, 279:251-258.
4. Hooper NM, Turner AJ: Membrane protein secretases. Biochem Soc Trans 1999, 27:211-257.
5. Fitzgerald ML, Wang Z, Park PW, Murphy G, Bernfield M: Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol 2000, 148:811-824.
6. Beauvais DM, Rapraeger AC: Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2004, 2:3-15.
7. Wilcox-Adelman SA, Denhez F, Iwabuchi T, Saoncella S, Calautti E, Goetinck PF: Syndecan-4: dispensable or indispensable? Glycoconj J 2002, 19:305-13.
8. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999, 68:729-777.
9. Mun-Bryce S, Rosenberg GA: Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab 1998, 18:1163-1172.
10. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH: Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A 1993, 90:2291-2294.
11. Grinberg LM, Abramova FA, Yampolskaya OV, Walker DH, Smith JH: Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod Pathol 2001, 14:482-495.
12. Vasconcelos D, Barnewall R, Babin M, Hunt R, Estep J, Nielsen C, Carnes R, Carney J: Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Lab Invest 2003, 83:1201-1209.
13. Klichko VI, Miller J, Wu A, Popov SG, Alibek K: Anaerobic induction of Bacillus anthracis hemolytic activity. Biochem Biophys Res Commun 2003, 303:855-862.
14. Read TD, Peterson SN, Tourasse N, Baillie LW, Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen JA, Gill SR, Holtzapple EK, Okstad OA, Helgason E, Rilstone J, Wu M, Kolonay JF, Beanan MJ, Dodson RJ, Brinkac LM, Gwinn M, DeBoy RT, Madpu R, Daugherty SC, Durkin AS, Haft DH, Nelson WC, Peterson JD, Pop M, Khouri HM, Radune D, Benton JL, Mahamoud Y, Jiang L, Hance IR, Weidman JF, Berry KJ, Plaut RD, Wolf AM, Watkins KL, Nierman WC, Hazen A, Cline R, Redmond C, Thwaite JE, White O, Salzberg SL, Thomason B, Friedlander AM, Koehler TM, Hanna PC, Kolsto AB, Fraser CM: The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 2003, 423:81-86.
15. Johansen T, Bjorkoy G, Overvatn A, Diaz-Meco MT, Traavik T, Moscat J: NIH 3T3 cells stably transfected with the gene encoding phosphatidylcholine- hydrolyzing phospholipase C from Bacillus cereus acquire a transformed phenotype. J Mol Cell Biol 1994, 14:646-654.
16. Firth JD, Putnins EE, Larjava H, Uitto VJ: Exogenous phospholipase C stimulates epithelial cell migration and integrin expression in vitro. Wound Repair Regen 2001, 9:86-94.
17. Moayeri M, Leppla SH: The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol 2004, 7:19-24.
18. Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD, Ahn NG, Oskarsson MK, Fukasawa K, Paull KD, Vande Woude GF: Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 1998, 280:734-737.
19. Moayeri M, Haines D, Young HA, Leppla SH: Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest 2003, 112:670-682.
20. Smith H, Stoner HB: Anthrax toxic complex. Fed Proc 1967, 26:1554-1557.
21. Warfel JM, Steele AD, D'Agnillo F: Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol 2005, 166:1871-1881.
22. Fouquet S, Lugo-Martinez VH, Faussat AM, Renaud F, Cardot P, Chambaz J, Pincon-Raymond M, Thenet S: Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes. J Biol Chem 2004, 279:43061-43069.
23. Kirby JE: Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun 2004, 72:430-439.
24. Kassam A, Der SD, Mogridge J: Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin. Cell Microbiol 2005, 7:281-292.
25. Ivanov AI, Nusrat A, Parkos CA: Endocytosis of the apical junctional complex: mechanisms and possible roles in regulation of epithelial barriers. Bioessays 2005, 27:356-365.
26. Arribas J, Borroto A: Protein ectodomain shedding. Chem Rev 2002, 102:4627-4638.
27. Wong WS, Leong KP: Tyrosine kinase inhibitors: a new approach for asthma. Biochim Biophys Acta 2004, 1697:53-69.
28. Mahabeleshwar GH, Kundu GC: Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa Bmediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3′-kinase activity in breast cancer cells. J Biol Chem 2003, 278:6209-6221.
29. Ralevic V, Burnstock G: Receptors for purines and pyrimidines. Pharmacol Rev 1998, 50:413-92.
30. Keradmand F, Werb Z: Shedding light on sheddases: role in growth and development. BioEssays 2002, 24:8-12.
31. Zhang YL, Keng YF, Zhao Y, Wu L, Zhang ZY: Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases. J Biol Chem 1998, 15:12281-12287.
32. Stoker AW: Protein tyrosine phosphatases and signalling. J Endocrinol 2005, 185:19-33.
33. McCain DF, Wu L, Nicke P, Kassack MU, Kreimeyer A, Gagliardi A, Collins DC, Zhang ZY: Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases. J Biol Chem 2004, 279:14713-14725.
34. Park JM, Ng VH, Maeda S, Rest RF, Karin M: Anthrolysin O and other Gram-positive cytolysins are Toll-like receptor agonists. J Exp Med 2004, 200:1647-1655.
35. Sawai T, Usui N, Dwaihy J, Drongowski RA, Abe A, Coran AG, Harmon CM: The effect of phospholipase A2 on bacterial translocation in a cell culture model. Pediatr Surg Int 2002, 16:262-266.
36. Popov SG, Popova TG, Hopkins S, Weinstein RS, MacAfee R, Fryxell KJ, Chandhoke V, Bailey C, Alibek K: Effective antiprotease-antibiotic treatment of experimental anthrax. BMC Infect Dis 2005, 5:25-39.
37. Li L, Chaikof EL: Mechanical stress regulates syndecan-4 expression and redistribution in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2002, 22:61-68.
38. Higashiyama S, Nanba D: ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. Biochim Biophys Acta 2005, 1751:110-117.
39. Timmermann M, Hogger P: Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes. Free Radic Biol Med 2005, 39:98-107.
40. Aktories K, Barbieri JT: Bacterial cytotoxins: targeting eukaryotic switches. Nat Rev Microbiol 2005, 3:397-410.
41. Kato M, Saunders S, Nguyen H, Bernfield M: Loss of cell surface syndecan-1 causes epithelia to transform into anchorageindependent mesenchyme-like cells. Mol Biol Cell 1995, 6:559-576.
42. Smith H, Keppie J, Stanley JL: The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by B. anthracis in vivo. Br J Exp Pathol 1955, 36:460-472.
43. Mikshis NI, Eremin SA, Bolotnikova MF: Correlation of the virulence of Bacillus anthracis with expression of signs, coded for by chromosomal genes. Mol Gen Mikrobiol Virusol 1999, 4:25-28.
44. Shannon JG, Ross CL, Koehler TM, Rest RF: Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin. Infect Immun 2003, 71:3183-3189.
45. Popov SG, Popova TG, Grene E, Klotz F, Cardwell J, Bradburne C, Jama Y, Maland M, Wells J, Nalca A, Voss T, Bailey C, Alibek K: Systemic cytokine response in murine anthrax. Cell Microbiol 2004, 6:225-233.
46. Nguyen A, Chen P, Cai H: Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells. FEBS Lett 2004, 572:307-313.
47. An SS, Fabry B, Mellema M, Bursac P, Gerthoffer WT, Kayyali US, Gaestel M, Shore SA, Fredberg JJ: Role of heat shock protein 27 in cytoskeletal remodeling of the airway smooth muscle cell. J Appl Physiol 2004, 96:1701-1713.
48. McMullen ME, Bryant PW, Glembotski CC, Vincent PA, Pumiglia KM: Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J Biol Chem 2005, 280:20995-21003.
49. Huffman DL, Abrami L, Sasik R, Corbeil J, Goot F, Aroian R: Mitogen-activated protein kinase pathways defend against bacterial pore-forming toxins. Proc Nat Acad Sci USA 2004, 101:10995-11000.
50. Kevil CG, Oshima T, Alexander JS: The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability. Endothelium 2001, 8:107-116.
51. Salles II, Tucker AE, Voth DE, Ballard JD: Toxin-induced resistance in Bacillus anthracis lethal toxin-treated macrophages. Proc Nat Acad Sci USA 2003, 100:12426-12431.
52. Johnson GB, Brunn GJ, Platt JL: An endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through toll-like receptor 4. J Immun 2004, 172:20-24.